Intelligent OMICS Ltd (Intellomx) is a UK-based translational company converting Big Data into biological intelligence.
We use public and proprietary information including transcriptomics, genomics, proteomics, metabolomics and real patient data to discover new drugs and biomarkers.
Our systems approach is called for "Intuitive Informed Intelligence". Our technology approach is based on high speed creation of Artificial Neural Networks (ANNs) which can evaluate tens of millions of data in short period of time, to identity key drivers for systems biology. And to connect these drives to therapeutic modalities including new drugs, repurposed drugs and biomarker panels for disease.
Intellomx uses novel proprietary Artificial Intelligence approaches applied to translational biology to
discover new drugs for old diseases
identify existing drugs for new targets
create new diagnostics to stratify patient populations
We transform biological data into clinical benefit!